On 3 November 2021, Novartis agreed to sell 53.3 million Roche bearer shares in a bilateral transaction to Roche for a consideration of CHF 19 billion. Novartis had acquired the stake between 2001 and 2003. The transaction is subject to the approval by the shareholders of Roche.